Efsubaglutide Alfa Injection

Efsubaglutide Alfa · Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Efsubaglutide Alfa Injection, covering 2025-03-28 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT) [Phase 2, Phase 3]

See pricing